Stay updated on Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Sign up to get notified when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.

Latest updates to the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.6.4 was released, replacing the previous v3.6.3 version. This reflects a minor maintenance update to the page build rather than any new or altered content on the study details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.6.3 is now displayed, replacing the previous v3.6.2. This indicates a minor page update; no study content or essential details appear to be changed based on the available data.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This appears to be a maintenance update and does not change study details or participant information.SummaryDifference0.1%

- Check44 days agoChange DetectedRecruitment status on the study page now indicates no participants are being enrolled. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment labeling along with a new revision tag.SummaryDifference0.5%

- Check51 days agoChange DetectedThe page revision label was updated to v3.5.5. This indicates a minor update to the page's metadata or formatting.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.5.4 indicates a new build of the ClinicalTrials.gov interface. This is a routine release update and does not modify the listed study details or eligibility criteria.SummaryDifference0.1%

Stay in the know with updates to Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.